FR7254M - - Google Patents

Info

Publication number
FR7254M
FR7254M FR133764A FR133764A FR7254M FR 7254 M FR7254 M FR 7254M FR 133764 A FR133764 A FR 133764A FR 133764 A FR133764 A FR 133764A FR 7254 M FR7254 M FR 7254M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR133764A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR7254M publication Critical patent/FR7254M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR133764A 1966-09-27 1967-12-26 Expired FR7254M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2213566A IT1053661B (it) 1966-09-27 1966-09-27 Ammidi dell acido 3 5 metil 5 3 pirazol carbossilico

Publications (1)

Publication Number Publication Date
FR7254M true FR7254M (fr) 1969-09-08

Family

ID=11192002

Family Applications (1)

Application Number Title Priority Date Filing Date
FR133764A Expired FR7254M (fr) 1966-09-27 1967-12-26

Country Status (9)

Country Link
BE (1) BE704290A (fr)
CH (1) CH479588A (fr)
DE (1) DE1670466A1 (fr)
ES (1) ES345849A1 (fr)
FR (1) FR7254M (fr)
GB (1) GB1209326A (fr)
IT (1) IT1053661B (fr)
NL (1) NL6713145A (fr)
SE (1) SE333147B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
EP1653949A4 (fr) * 2003-08-07 2009-04-22 Merck & Co Inc Carboxamides de pyrazole utilises comme inhibiteurs de la dehydrogenase-1 11-beta-hydroxysteroide
EP1637522A1 (fr) * 2004-09-16 2006-03-22 Laboratorios Del Dr. Esteve, S.A. Composés de pyrazolines substituées pour réduire des triglycerides dans le sang
KR20060135815A (ko) * 2004-02-17 2006-12-29 라보라토리오스 델 드라. 에스테브.에스.에이. 혈중 트리글리세리드를 감소시키기 위한 치환된 피라졸린화합물
TW200533657A (en) 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
US7998996B2 (en) 2004-02-17 2011-08-16 Laboratorios Del Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
US7897589B2 (en) 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743889A1 (fr) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Composés de pyrazolines substituées ayant une stereochimie predeterminèe pour réduire des triglycerides dans le sang
WO2007009702A2 (fr) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Composes de pyrazoline substitues, leur preparation et leur utilisation comme medicaments
WO2007009706A2 (fr) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Composes de pyrazoline substitues, leur preparation et utilisation comme medicaments
EP1746090A1 (fr) * 2005-07-15 2007-01-24 Laboratorios del Dr. Esteve S.A. Composés de pyrazolines substituées ayant une stereochimie predeterminèe pour réduire des triglycerides dans le sang
EP1743892A1 (fr) 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Composés pyrazoline substitués, leur préparation et utilisation comme médicaments
EP1743890A1 (fr) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Dérivés 4,5-dihydro-1H-pyrazole, leur, préparation et utilisation comme médicaments.
EP1950202A1 (fr) * 2007-01-24 2008-07-30 Laboratorios del Dr. Esteve S.A. Composés de pyrazoline substitués, leur composition et utilisation en tant que médicaments présentant une activité inhibitrice de l'ACAT

Also Published As

Publication number Publication date
ES345849A1 (es) 1968-11-16
SE333147B (sv) 1971-03-08
IT1053661B (it) 1981-10-10
GB1209326A (en) 1970-10-21
DE1670466A1 (de) 1972-01-27
NL6713145A (fr) 1968-03-28
CH479588A (it) 1969-10-15
BE704290A (fr) 1968-02-01

Similar Documents

Publication Publication Date Title
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU1144366A (fr)
AU6703465A (fr)
AU612166A (fr)
AU5895065A (fr)
AU1111066A (fr)
AU218666A (fr)
BE447356A (fr)
BE618801A (fr)
AU407778B2 (fr)
BE704290A (fr)
AU415780B2 (fr)
BE694475A (fr)
AU411645B2 (fr)
AU6852465A (fr)
AU855865A (fr)
AU92366A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse